Start with a free account for 12 free CME credits. Already a subscriber? Sign in.
Chapter 2

Paper Chase #1 - CV and Renal Outcomes with Empagliflozin in Heart Failure

Tom Robertson, MD and Steve Biederman, MD
00:00
07:35
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

Among patients with heart failure, SGLT inhibitors improved rate of hospitalizations and decline in renal function regardless of diabetes status

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To earn CME for this chapter, you need to subscribe.

Sign up today for full access to all episodes and earn CME.

3.5 AAPA Category 1 Credits certified by Hippo (2020-2021)